Qube Research & Technologies LTD Fulgent Genetics, Inc. Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$29.23 - $40.28 $118,206 - $162,892	-4,044 Reduced 20.15%	16,022 $477,000
Q3 2022 Nov 14, 2022	BUY	$37.92 - $63.74 $105,114 - $176,687	2,772 Added 16.03%	20,066 $765,000
Q2 2022 Aug 15, 2022	BUY	$47.98 - $62.75 $829,766 - $1.09 Million	17,294 New	17,294 $943,000
Q2 2020 Aug 14, 2020	SELL	$8.89 - $18.28 $146,489 - $301,217	-16,478 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$6.75 - $19.75 $135,769 - $397,251	-20,114 Reduced 54.97%	16,478 $177,000
Q4 2019 Feb 13, 2020	BUY	$9.29 - $15.82 $339,939 - $578,885	36,592 New	36,592 $472,000

200

16M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $513M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.